Khiron Life Sciences: The Latin American Cannabis King > As investor look for the next multi-bagger opportunity in the cannabis space, we think Khiron should have a place in your portfolio due to its solid positioning in Latin America and strategic value to potential acquirers. Its partnership with Dixie is a game changer as it enters the U.S. market targeting the Hispanic population. Compare to some of the biggest names such as Canopy, Aurora, or Aphria, Khiron deserves more attention. We believe that the easy money has made in the Canadian cannabis space after the 2016-2018 bull market and investors should increase exposure to newer markets including the U.S. and Mexico where the next multi-bagger opportunities will most likely come from. With Mexico heading down the path of legalization, it looks awfully like Canada in 2015 when Trudeau was elected on the back of his promise to legalize cannabis. Looking at what happened to the Canadian cannabis stocks since 2015, Khiron looks very promising from a risk and reward perspective.
The above is an extract from an online article